Diligence memo · auto-generated · as of July 2, 2026
Villya Llc
Villya Llc looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Villya Llc operates in Pharmaceuticals, based in MELBOURNE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Villya Llc has raised $250K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $250K on 2023-12-08.
Most recent recorded round closed around 2023-12-08.
Valuation (modeled)modeled
Provath models Villya Llc at approximately $1.6M (range $140K–$6.3M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Pre-Seed Pharmaceuticals companies in 2022–2024 (38 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 2.6 yr ago; this sector typically re-raises about every 13 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
Comparablesmixed
Capital scale ranks ahead of 6% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 3% of those peers.
Closest niche peers: Eleison Pharmaceuticals Inc, Telomir Pharmaceuticals, Inc., Drusolv Therapeutics, Inc., TF Tech Ventures, Inc., Thyron Pharmaceuticals, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.